Publications by authors named "Rosa Frias"

Claim this Profile
D
Development of two SYBR Green quantitative real-time PCR assays for the detection and quantification of species causing trunk diseases in grapevine and almond.
Greta Dardani, Tawanda E Maguvu, Rosa Frias, Davide Spadaro, Florent Trouillas

Plant Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating pistachio rootstock tolerance to Phytophthora root and crown rot.
Alejandro Ivan Hernandez-Rosas, Mohamed Taieb Nouri, Rosa Frias, Florent Trouillas

Plant Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome sequencing and analysis of isolates of Cytospora sorbicola and Cytospora plurivora associated with almond and peach canker.
Tawanda E Maguvu, Rosa J Frias, Florent P Trouillas

PLoS One· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Report of Causing Red Leaf Blotch of Almond in California.
Florent Trouillas, Alejandro Ivan Hernandez-Rosas, Rosa Frias, Tawanda E Maguvu, Cameron Zuber

Plant Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenicity, phylogenomic, and comparative genomic study of sensu lato affecting sweet cherry in California.
Tawanda E Maguvu, Rosa J Frias, Alejandro I Hernandez-Rosas, Erin Shipley, Greta Dardani

Microbiol Spectr· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phylogenomic analyses and comparative genomics of Pseudomonas syringae associated with almond (Prunus dulcis) in California.
Tawanda E Maguvu, Rosa J Frias, Alejandro I Hernandez-Rosas, Brent A Holtz, Franz J A Niederholzer

PLoS One· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC.
Joao V Alessi, Arielle Elkrief, Biagio Ricciuti, Xinan Wang, Alessio Cortellini, Rosa L Frias

J Thorac Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy.
Gonzalo Recondo, Linda Mahjoubi, Aline Maillard, Yohann Loriot, Ludovic Bigot, Rosa L Frias

NPJ Precis Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Correlation of English Language Proficiency and Indices of Stress and Anxiety in Migrants from Puerto Rico after Hurricane Maria: A Preliminary Study.
Yonatan Carl, Rosa L Frias, Sara Kurtevski, Tamara González Copo, Ana R Mustafa

Disaster Med Public Health Prep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer.
Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, David Planchard, Anas Gazzah, Rosa L Frias

Clin Cancer Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.
Andreas Varkaris, Anastasia Katsiampoura, Jennifer S Davis, Neeraj Shah, Michael Lam, Rosa Lizeth Frias

Br J Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting episodic memory formation for movie events.
Hanlin Tang, Jed Singer, Matias J Ison, Gnel Pivazyan, Melissa Romaine, Rosa Frias

Sci Rep· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.
Alice T Shaw, Luc Friboulet, Ignaty Leshchiner, Justin F Gainor, Simon Bergqvist, Rosa L Frias

N Engl J Med· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models.
Helen Y Zou, Luc Friboulet, David P Kodack, Lars D Engstrom, Qiuhua Li, Rosa L Frias

Cancer Cell· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived models of acquired resistance can identify effective drug combinations for cancer.
Adam S Crystal, Alice T Shaw, Lecia V Sequist, Luc Friboulet, Matthew J Niederst, Rosa L Frias

Science· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis